D. E. Shaw & Co., Inc. - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 50 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q2 2019$34,000
-35.8%
35,288
-16.1%
0.00%
Q1 2019$53,000
-86.4%
42,060
-65.0%
0.00%
-100.0%
Q4 2018$389,000120,0650.00%
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q3 2019.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders